Skip to main content
NSE - SMEListed
Sotac Pharmaceuticals Limited Logo

Sotac Pharmaceuticals Limited IPO

Sotac Pharmaceuticals Limited IPO

IPO Date :
Issue Price :
Allotment Date :
Listing Date :
List Price :
Lot Size:
Subscription:
Listed Price: ₹ 115.00 (+3.60%)

The Initial Public Offering of Sotac Pharmaceuticals Limited's culminated in its successful listing on 13-04-2023 at the NSE trading platform. The company secured 30,00,000 Shares through this capital market exercise, with 30,00,000 Shares allocated to new capital formation.

Investors participated within the price parameters of ₹105 to ₹111, with minimum investment requirements of 1200 shares. The subscription period from 29-03-2023 to 03-04-2023 witnessed active investor engagement across categories.

Following the subscription closure, share allotment was processed on 10-04-2023. The subsequent listing established a public market for the company's shares, enabling price discovery and secondary market trading for investors.

Sotac Pharmaceuticals IPO Details
Lot(s) Distribution

Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.

IPO Reservation
Sotac Pharmaceuticals IPO Key Performance Indicator
Company Financials ( In Lakhs )

Sotac Pharmaceuticals IPO About Company

Incorporated in 2015, Sotac Pharmaceuticals Limited, part of the Gujarat-based SOTAC Group, is engaged in manufacturing pharmaceutical products for various marketers on a loan license and contract manufacturing basis. Serving over 162 corporate clients, the company operates primarily on a principal-to-principal model. Established in 2017, its manufacturing facility has an annual capacity of 90 crore tablets and 14 crore capsules. Backed by promoters with over 59 years of combined industry experience, Sotac Pharmaceuticals continues to expand and strengthen its presence in the pharmaceutical sector.


Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."


Sotac Pharmaceuticals IPO Strength Factors

NA


Sotac Pharmaceuticals IPO Risk Factors

NA


Sotac Pharmaceuticals IPO Lead Manager(s)

  • Beeline Capital Advisors Private Limited

Sotac Pharmaceuticals IPO Promoter(s)

  1. Mr. Sharadkumar Dashrathbhai Patel
  2. Mr. Dineshkumar Babulal Gelot
  3. Mr. Vishalkumar Devrajbhai Patel
  4. Mr. Chetankumar Bachubhai Patel
  5. Mrs. Kiran Baldevbhai Jotania

Sotac Pharmaceuticals IPO Company Details

Sotac Pharmaceuticals Limited
Phone:
address:

Sotac Pharmaceuticals IPO Registrar

Kfin Technologies Limited
Name:
Phone:

Sotac Pharmaceuticals IPO FAQs